DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20191604

Assessment of drug-drug interactions in the prescription of elderly patients on cardiovascular drugs

Sneha C., Anuradha H. V., Srihari G. Kulkarni

Abstract


Background: Cardiovascular disease is one of the major causes of mortality and morbidity in a developing country like India. These patient’s prescription contains multiple drugs to reduce the mortality and morbidity and they also contain drugs for treatment of co morbidities leading to polypharmacy. The main objective of the study was to identify the pattern of drug- drug interaction (DDI) in patients on cardiovascular drugs with various co existing morbidities.

Methods: This study was conducted in the Department of General Medicine of a tertiary care center. Prescription of 200 patients were analysed for demographic details like gender, age, comorbidities and drugs prescribed. DDI were assessed using Micromedex software.

Results: In this study, conducted on the prescription of 200 elderly patients, 13 (66%) prescription had 408 DDI, of which 158 (39%) were major, 246 (60%) were moderate and 1 (0.02%) was contraindicated and 3 (0.007%) were minor.

Conclusions: It can be concluded from the present study that the risk of DDI increases with the increase in number of drugs in the prescription and there is increase in number of drugs in the prescription with the increase in number of co morbidities. The antiplatelet and anticoagulant group of drugs were responsible for majority of DDI, followed by antihypertensives and hypoglycaemic agents. Most of these DDI could be avoided with slight modification in the dosage regimen based on the pharmacokinetics and pharmacodynamics of the drug.


Keywords


Cardiovascular drugs, Drug-drug interaction, Major interaction, Moderate interaction

Full Text:

PDF

References


KD Tripathi. Textbook of Pharmacology. 7th ed. New Delhi: Jaypee brothers medical publishers; 2013: 728-734.

Katzung and Trevor. Important drug interaction and their mechanism. Basic and Clinical Pharmacology 13th ed. Mc Graw Hill; 2016:1522.

Central Statistics Office, Ministry of Statistics and Programme Implementation, Government of India. Situation analysis of elderly in India; 2011. Available at: http://www.mospi.nic.in/mospi_new/upload/elderly_in_India.pdf. Accessed on 26 March 2019.

SS M, MK S, Vishnu VG, Jose F, Siraj ST, Anand VP. The prevalence of polypharmacy in south indian patients: a pharmacoepidemiological approach. Ind J Pharm Prac. 2012;5(3):40.

Kevin C. Osterhoudt and Trevor M. Penning. Drug toxicity and poisoning. In: Brunton LL, Chabner BA, Knollman BC. eds. Goodman and Gillman's- The Pharmacological Basis of Therapeutics. 12th ed. New York: Mc Graw Hill; 2011: 96-97.

Fadare JO, Agboola SM, Opeke OA, Alabi RA. Prescription pattern and prevalence of potentially inappropriate medications among elderly patients in a Nigerian rural tertiary hospital. Therapeutics Clin Risk Man. 2013;9:115.

Sharma HL, Sharma KK. Principles of Pharmacology. 3rd ed. Hyderabad: Paras publishers; 2017.

IBM Micromedex®. Truven Health Micromedex Solutions 2016. Available at: https://www.micromedexsolutions.com/. Accessed on January 16, 2019.

Sharma S, Chhetri HP, Alam K. A study of potential drug-drug interactions among hospitalized cardiac patients in a teaching hospital in Western Nepal. Ind J Pharmacol. 2014;46(2):152.

Dutta M, Prashad L. Prevalence and risk factors of polypharmacy among elderly in india: evidence from SAGE data. Int J Public Ment Health Neurosci. 2015;2(2):11-6.

Ahmad A, Khan MU, Haque I, Ivan R, Dasari R, Revanker M, et al. Evaluation of potential drug-drug interactions in general medicine ward of teaching hospital in southern India. J Clin Diagn Res JCDR. 2015;9(2):FC10.

Pelliccia F, Rollini F, Marazzi G, Greco C, Gaudio C, Angiolillo DJ. Drug-drug interactions between clopidogrel and novel cardiovascular drugs. Euro J Pharmacol. 2015;765:332-6.

Corsonello A, Abbatecola AM, Fusco S, Luciani F, Marino A, Catalano S, et al. The impact of drug interactions and polypharmacy on antimicrobial therapy in the elderly. Clin Microbiol Inf. 2015;21(1):20-6.

Bucşa C, Farcaş A, Cazacu I, Leucuta D, Achimas-Cadariu A, et al. How many potential drug–drug interactions cause adverse drug reactions in hospitalized patients?. Euro J Internal Med. 2013;24(1):27-33.

Sehgal V, Bajwa SJ, Sehgal R, Bajaj A, Khaira U, Kresse V. Polypharmacy and potentially inappropriate medication use as the precipitating factor in readmissions to the hospital. J Fam Med Prim Care. 2013;2(2):194.

Kim HA, Shin JY, Kim MH, Park BJ. Prevalence and predictors of polypharmacy among Korean elderly. PloS One. 2014;9(6):e98043.

Basnet S, Paudel KR, Sah AK, Jha RK, Sah P, Adhikari S, et al. Prescribing pattern, polypharmacy and potentially inappropriate prescribing in hospitalized elderly patients: a retrospective study in a teaching hospital in Nepal. Int J Sci Rep. 2016;2(1):7-12.

Pallav S. Health impacts of yoga and pranayama: a state-of-the-art review. Int J Prev Med. 2012;3(7):444-58.

Saatcioglu F. Regulation of gene expression by yoga, meditation and related practices: a review of recent studies. Asian J Psychiatry. 2013;6(1):74-7.

Bhasin MK, Dusek JA, Chang BH, Joseph MG, Denninger JW, Fricchione GL, et al. Relaxation response induces temporal transcriptome changes in energy metabolism, insulin secretion and inflammatory pathways. PloS One. 2013;8(5):e62817.

Marshall H, Rebecca S, Terry Selfe KI. Effectiveness of yoga for hypertension: systematic review and meta-analysis. Evid Based Complement Alternat Med. 2013;649836.

Bhadra R, Ravakhah K, Ghosh RK. Herb-drug interaction: the importance of communicating with primary care physicians. Aus Med J. 2015;8(10):315.

Tannenbaum C, Sheehan NL. Understanding and preventing drug-drug and drug-gene interactions. Expert Rev Clin Pharmacol. 2014;7(4):533-44.

Verbeurgt P, Mamiya T, Oesterheld J. How common are drug and gene interactions? prevalence in a sample of 1143 patients with CYP2C9, CYP2C19 and CYP2D6 genotyping. Pharmacogen. 2014;15(5):655-65.

Thirumaran RK, Heck JW, Hocum BT. CYP450 genotyping and cumulative drug-gene interactions: an update for precision medicine. Per Med. 2016;13(1):5-8.